The device eases efficient monitoring and treatment of atrial arrhythmia, which is a rhythm disruption difficult to pick up with current equipment. Undetected, the condition can cause complications, extra costs and even death.
Dr. Nick Von Bergen presented for the company, which includes a larger team of scientists and managers. AtriAmp has been cleared for use by the FDA. Like 11 other “Diligent Dozen” finalists, Von Bergen presented Wednesday to judges and others during a prelude to the Wisconsin Entrepreneurs’ Conference.
See a recent article on the company: https://www.wisbusiness.com/2021/new-medical-device-aids-in-treatment-of-cardiac-surgery-patients/